Newsroom
October 1, 2024
Pancreatic ductal adenocarcinoma (PDAC), a certain type of pancreatic cancer, is a ruthless killer with an average five-year survival rate of less than 10%. Most patients are diagnosed at a late stage when the cancer has already spread throughout their bodies. And the problem is only growing worse. By 2030, pancreatic cancer is expected […]
September 18, 2024
Weight-maintaining hormone key to brain-signal transmission New research is more closely linking obesity to dementia. Higher levels of leptin, a hormone that helps maintain normal body weight, is associated with better signal-transmitting brain white matter in middle-aged adults, according to a study by The University of Texas Health Science Center at San Antonio (UT Health […]
September 5, 2024
A team of researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) are among four teams from across the United States that have been selected to launch community engagement centers thanks to a generous contribution from the American Heart Association and the Robert Wood Johnson Foundation. A total gift of $20 million […]
August 20, 2024
Lack of oxygen can sensitize nerve cells, leading to long-term pain More than 100 million people worldwide are affected by obstructive sleep apnea. This health condition causes a person to stop breathing numerous times while they are sleeping. Reduced sleep time and sleep quality can lead to numerous health problems including obesity, high blood pressure, […]
August 8, 2024
A drug effective in treating breast cancer shows new promise in addressing breast cancer with brain metastases or recurrent glioblastoma, as reported by results of a prospective window-of-opportunity trial at the University of Texas Health Science Center at San Antonio (UT Health San Antonio). The window trial, in which patients agreed to receive a novel […]
July 31, 2024
Scientists from The University of Texas Health Science Center at San Antonio, also known as UT Health San Antonio, led a pilot study of the Food and Drug Administration-approved antiretroviral drug lamivudine, to determine if it could be a potential treatment for Alzheimer’s disease. Almost half of what makes up the human genome are […]
